"I think we have to put the brakes on and truly ask the companies: How does this play out? What does this look like? And I can see all kinds of cases in front of our court that deal with proprietary information as we move forward. What accounts for what's accepted as "generally accepted accounting principles"? And obviously, there are different countries that have robust R&D tax credits, whether they be refundable. I think of countries like China and so forth that have significant R&D tax credits and so forth that can be applied and yet the U.S. credits cannot be applied because it's not refundable. That is a great concern. You start going down these paths, we need a level playing field."